Status:
COMPLETED
Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Exercise
Detraining
Eligibility:
FEMALE
48-60 years
Phase:
NA
Brief Summary
While "conditioning" by exercise training has been widely evaluated, the available literature on "passive deconditioning" (i.e. forced deconditioning) is predominately limited to studies with or with ...
Eligibility Criteria
Inclusion
- (early)postmenopausal women, ( normal menopause, 1-5 years post)
- Osteopenia and osteoporosis (Bone Mineral Density \<-1.0 SD T-Score)
Exclusion
- BMD \<-4.0 SD T-Score
- Prevalent clinical, low-trauma fractures
- Diseases and drugs with relevant effects on bone and muscle metabolism (e.g. glucocorticoids \>7.5 mg/d or bisphosphonate therapy); individual case assessment
- Diseases and drugs with relevant effects on cardiometabolic risk factors (e.g. severe hypertension with corresponding medical therapy); individual case assessment
- Severe cardiovascular events (e.g. stroke, coronary infarction) in the past.
- Other conditions, diseases that exclude exercise training or testing
Key Trial Info
Start Date :
March 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04420806
Start Date
March 14 2020
End Date
October 30 2020
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Medical Physics, Friedrich-Alexanden University Erlangen-Nürnberg
Erlangen, Germany, 91052